Kaletra, Lopinavir/Ritonavir

Kaletra, Lopinavir/Ritonavir Newswire

Comprehensive Real-Time News Feed for Kaletra, Lopinavir/Ritonavir (generic).

Results 1 - 20 of 34 in Kaletra, Lopinavir/Ritonavir (generic)

  1. HIV Drug Therapy: Darunavir/Ritonavir Protease Inhibitor Monotherapy Less Effective than 3-Drug ARTRead the original story w/Photo

    Monday Nov 10 | HIV and Hepatitis

    Monotherapy with ritonavir-boosted darunavir results in a lower rate of viral suppression after 48 weeks when compared to darunavir/ritonavir plus 2 nucleoside/nucleotide reverse transcriptase inhibitors , but may be just as effective as 3-drug therapy in people with nadir CD4 cell counts above 200 cells/mm3, according to a 48-week analysis of the PROTEA study presented last week at the HIV Drug Therapy Glasgow conference . Monotherapy with a boosted protease inhibitor has been proposed as a form of maintenance therapy for people who have achieved viral load suppression, as a means of reducing toxicity and cost while preserving future treatment options in the event of virological rebound.

    Comment?

  2. Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapyRead the original story w/Photo

    Friday Nov 7 | Aidsmap

    Our award-winning series of patient information booklets. Each title provides a comprehensive overview of one aspect of living with HIV.

    Comment?

  3. Generic antiretrovirals could save NHS 1.25 billion over 5 years, study findsRead the original story w/Photo

    Tuesday Nov 4 | Aidsmap

    Our award-winning series of patient information booklets. Each title provides a comprehensive overview of one aspect of living with HIV.

    Comment?

  4. Efavirenz compromises hormonal contraceptive implantRead the original story w/Photo

    Monday Nov 3 | Aidsmap

    Our award-winning series of patient information booklets. Each title provides a comprehensive overview of one aspect of living with HIV.

    Comment?

  5. NNRTIs and protease inhibitors both good for first ART, channelling affects choicesRead the original story w/Photo

    Oct 22, 2014 | Aidsmap

    Our award-winning series of patient information booklets. Each title provides a comprehensive overview of one aspect of living with HIV.

    Comment?

  6. Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir ...Read the original story

    Oct 12, 2014 | CiteULike

    Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients The predictors of Fanconi syndrome accompanied by renal function decline with use of the antiretroviral tenofovir disoproxil fumarate have not been assessed. In addition, the natural history of renal recovery from FS after TDF discontinuation is not well-described.

    Comment?

  7. India set to run out of critical free drug for HIV/AIDS programmeRead the original story w/Photo

    Oct 2, 2014 | Rediff.com

    India could run out of a critical medicine in its free HIV/AIDS drugs programme in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Missed dosages for long durations can increase patients' drug resistance and result in faster spread of the virus, while changes in medication regimens expose patients to side effects.

    Comment?

  8. India Set to Run Out of Critical Free Drug for HIV/AIDS ProgramRead the original story w/Photo

    Oct 2, 2014 | The Irrawaddy Newsmagazine

    India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Missed dosages for long durations can increase patients' drug resistance and result in faster spread of the virus, while changes in medication regimens expose patients to side effects.

    Comment?

  9. AIDS In India: India set to run out of critical free drug for HIV/AIDS programRead the original story w/Photo

    Oct 1, 2014 | Medical Daily

    India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Missed dosages for long durations can increase patients' drug resistance and result in faster spread of the virus, while changes in medication regimens expose patients to side effects.

    Comment?

  10. Exclusive: India set to run out of critical free drug for HIV/AIDS programRead the original story w/Photo

    Oct 1, 2014 | Reuters

    India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Missed dosages for long durations can increase patients' drug resistance and result in faster spread of the virus, while changes in medication regimens expose patients to side effects.

    Comment?

  11. Janssen Pharmaceutical Inc. Release: Prezcobix??? Now Available For Canadians Living With HIVRead the original story

    Sep 17, 2014 | BioSpace

    "PREZCOBIX is an important new option in HIV treatment as it helps physicians simplify medical regimes and reduces the burden often associated with taking multiple pills daily." Patients with conditions like HIV that require either taking medication more than once a day or taking multiple medications may find it difficult to adhere to their treatment schedules.

    Comment?

  12. HIV drug shortage fearRead the original story

    Sep 12, 2014 | The Telegraph

    New Delhi, Sept. 12: Coalitions of people infected with the human immunodeficiency virus have expressed concern at what they claim is a looming shortage of government-supplied anti-HIV drugs that are used to keep them in good health and prolong their lives.

    Comment?

  13. Antiretroviral therapy response among HIV-2 infected patients: a systematic reviewRead the original story

    Aug 25, 2014 | BioMed Central

    Few data are available on antiretroviral therapy response among HIV-2 infected patients.

    Comment?

  14. Studies from University of Turin Further Understanding of Enzyme...Read the original story

    Aug 13, 2014 | Hispanic Business

    Their improved pharmacokinetic profiles can be achieved through the concomitant administration of low doses of ritonavir , a protease inhibitor currently used as a booster, increasing the exposure of companion drugs."

    Comment?

  15. Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4...Read the original story

    Aug 5, 2014 | CiteULike

    Analysis of single-nucleotide polymorphisms in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs BACKGROUND:Drug metabolism via the cytochrome P450 system has emerged as an important determinant in the occurrence of several drug interactions .

    Comment?

  16. Protease inhibitor and NRTIs safe, effective in HIV treatmentRead the original story w/Photo

    Jul 19, 2014 | PhysOrg Weblog

    An HIV treatment regimen of a boosted protease inhibitor combined with nucleoside reverse-transcriptase inhibitors is safe and effective in low-resource settings, according to a study published in the July 17 issue of the New England Journal of Medicine .

    Comment?

  17. Protease inhibitor therapy doesn't reduce the risk of malaria for HIV-positive pregnant womenRead the original story

    Jul 17, 2014 | Aidsmap

    Antiretroviral therapy based on the protease inhibitor lopinavir/ritonavir does not reduce the risk of malaria among HIV-positive pregnant women, research published in the online edition of the Journal of Infectious Diseases shows.

    Comment?

  18. HIV Treatments Reduce Malaria Liver Stage Burden in a Non-Human...Read the original story

    Jul 13, 2014 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

    Comment?

  19. HIV Detected in Mississippi Baby Who Appeared CuredRead the original story w/Photo

    Jul 11, 2014 | HIV and Hepatitis

    A child in Mississippi who had undetectable HIV viral load for more than 2 years off antiretroviral treatment and was heralded as a rare case of "functional cure" has been found to still be infected with the virus, researchers announced this week, tempering optimism about one cure research approach.

    Comment?

  20. Inflammatory, procoagulant markers and HIV residual viremia in...Read the original story

    Jul 9, 2014 | BioMed Central

    Protease inhibitor monotherapy is associated with more frequent episodes of viral rebounds above 50 copies/mL than triple therapy.

    Comment?